A New Model Approach to Drug Shortage Prevention
18 March, 2024
In an interview with Bioprocess Online, Diane Hustead, Executive Director, Regulatory Affairs, Merck & Co., Inc., and current chair of the ISPE Drug Shortages Initiative Team, discusses updates to the 2023 ISPE Drug Shortages Prevention Model. The revised Drug Shortages Prevention Model focuses on 12 performance areas to guide pharmaceutical manufacturers in helping to prevent shortages. In the article, Hustead weighs in on the evolution of the pharmaceutical industry since 2014, when the initial ISPE Drug Shortages Prevention Plan was released, noting the growing need to account for global supply chain challenges and adapt to shifting regulatory expectations.
About Bioprocess Online
Bioprocess Online is part of the Life Science Connect media group. The publication provides technical information, industry knowledge, and content for the biotherapeutic community. Audiences include bioprocess engineers, scientists, bioprocessing managers, biotechnology producers, consultants, QA/QC, project managers, directors, purchasers, marketers, and those involved in biopharmaceutical supply chain or facilities management.